Wednesday, December 19, 2012

Company announcements: Shang Asia 2kHK$, SingPost, TianjinZUS$

Shang Asia 2kHK$ - MISCELLANEOUS

Announcement Type: MISCELLANEOUS
Company: SHANGRI-LA ASIA LIMITED
Stock Code/Name: S07 - Shang Asia 2kHK$

MISCELLANEOUS
* Asterisks denote mandatory information
Name of Announcer * SHANGRI-LA ASIA LIMITED  
Company Registration No. 17607  
Announcement submitted on behalf of SHANGRI-LA ASIA LIMITED  
Announcement is submitted with respect to * SHANGRI-LA ASIA LIMITED  
Announcement is submitted by * Tracy Kong  
Designation * Assistant Company Secretary  
Date & Time of Broadcast 19-Dec-2012 17:38:35  
Announcement No. 00061  
>> ANNOUNCEMENT DETAILS
The details of the announcement start here ...
Announcement Title * Connected Transactions relating to Sale and Purchase of 25% Equity Interests in the Joint Venture Companies established at Bayuquan, Yingkou City, Liaoning Province, the PRC  
Description
   
Attachments
Total size = 210K
(2048K size limit recommended)


SingPost - MISCELLANEOUS

Announcement Type: MISCELLANEOUS
Company: SINGAPORE POST LIMITED
Stock Code/Name: S08 - SingPost

MISCELLANEOUS
* Asterisks denote mandatory information
Name of Announcer * SINGAPORE POST LIMITED  
Company Registration No. 199201623M  
Announcement submitted on behalf of SINGAPORE POST LIMITED  
Announcement is submitted with respect to * SINGAPORE POST LIMITED  
Announcement is submitted by * Genevieve Tan McCully (Mrs)  
Designation * Company Secretary  
Date & Time of Broadcast 19-Dec-2012 17:48:50  
Announcement No. 00071  
>> ANNOUNCEMENT DETAILS
The details of the announcement start here ...
Announcement Title * Completion of Sale of a 17% Stake in ePDS, Inc. to ePLDT, Inc. and Sale of a 3% Stake in ePDS, Inc. to DataPost Pte Ltd  
Description
   
Attachments
Total size = 17K
(2048K size limit recommended)


TianjinZUS$ - ANNOUNCEMENT OF CESSATION AS NON-EXECUTIVE DIRECTOR

Announcement Type: ANNOUNCEMENT OF CESSATION
Company: TIANJIN ZHONG XIN PHARM GROUP
Stock Code/Name: T14 - TianjinZUS$

ANNOUNCEMENT OF CESSATION AS NON-EXECUTIVE DIRECTOR *
* Asterisks denote mandatory information
Name of Announcer * TIANJIN ZHONG XIN PHARM GROUP  
Company Registration No. 120000000004711  
Announcement submitted on behalf of TIANJIN ZHONG XIN PHARM GROUP  
Announcement is submitted with respect to * TIANJIN ZHONG XIN PHARM GROUP  
Announcement is submitted by * Jiao Yan  
Designation * Secretary to the Board  
Date & Time of Broadcast 19-Dec-2012 17:12:23  
Announcement No. 00034  
>> ANNOUNCEMENT DETAILS
The details of the announcement start here ...
Name of person * Shao Biao  
Age * 62  
Is Effective Date of Cessation known? * Yes  
If yes, please provide the date * 18-12-2012  
Detailed Reason(s) for cessation *
He has stepped down as Director.  
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting? * No 
If yes, please elaborate * NA 
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer? * No 
If yes, please elaborate * NA 
Any other relevant information to be provided to shareholders of the listed issuer? * No 
If yes, please elaborate * NA 
Date of Appointment to current position * 31-01-2007  
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.) * Non-Executive Director  
Role and responsibilities *
in charge of the strategic work  
Does the AC have a minimum of 3 members (taking into account this cessation)? *Yes 
Number of Independent Directors currently resident in Singapore (taking into account this cessation) *2 
Number of cessations of appointments specified in Listing Rule 704(7) or Catalist Rule 704(6) over the past 12 months *2 
Interest * in the listed issuer and its subsidiaries *
NIL  
Familial relationship with any director and/or substantial shareholder of the listed issuer or of any of its principal subsidiaries *
NIL  
>> OTHER DIRECTORSHIPS
Past (for the last 5 years) *
he has been the secretary to the party’s committee and the vice-chairman of Tianjin Pharmaceutical Group Co. Ltd since November 2005.  
Present *
NIL  
Footnotes
   
Attachments
Total size = 0
(2048K size limit recommended)


TianjinZUS$ - ANNOUNCEMENT OF APPOINTMENT OF SUPERVISOR

Announcement Type: ANNOUNCEMENT OF APPOINTMENT
Company: TIANJIN ZHONG XIN PHARM GROUP
Stock Code/Name: T14 - TianjinZUS$

ANNOUNCEMENT OF APPOINTMENT OF SUPERVISOR *
* Asterisks denote mandatory information
Name of Announcer * TIANJIN ZHONG XIN PHARM GROUP  
Company Registration No. 120000000004711  
Announcement submitted on behalf of TIANJIN ZHONG XIN PHARM GROUP  
Announcement is submitted with respect to * TIANJIN ZHONG XIN PHARM GROUP  
Announcement is submitted by * Jiao Yan  
Designation * Secretary to the Board  
Date & Time of Broadcast 19-Dec-2012 17:46:40  
Announcement No. 00068  
>> ANNOUNCEMENT DETAILS
The details of the announcement start here ...
Date of Appointment * 18-12-2012  
Name of Person* Yu Hong  
Age * 38  
Country of principal residence * China  
The Board's comments on this appointment (including rationale, selection criteria, and the search and nomination process) * approve of the decision of the board of supervisors of the Company  
Whether appointment is executive, and if so, the area of responsibility *
Supervision work  
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.) Supervisor  
Working experience and occupation(s) during the past 10 years *
From July 1997 to April 2002, she was working in the audit department of Tianjin Pharmaceutical Group Co., Ltd. From April 2002 to November 2008, she held the position of Senior Executive in the Accounting Department of Tianjin Pharmaceutical Group Co., Ltd.. From November 2008 to November 2011, she held the position of Deputy Director of the Accounting Department of Tianjin Pharmaceutical Group Co., Ltd.. From November 2011 to date, she is the Director of the Finance Department of Tianjin Pharmaceutical Group Co., Ltd.  
Interest * in the listed issuer and its subsidiaries *
NIL  
Familial relationship with any director and/or substantial shareholder of the listed issuer or of any of its principal subsidiaries *
NIL  
Conflict of interests (including any competing business) *
NIL  
>> OTHER DIRECTORSHIP#
# These fields are not applicable for announcements of appointments pursuant to Listing Rule 704(9) or Catalist Rule 704(8).
Past (for the last 5 years)
NIL  
Present
NIL  
>> INFORMATION REQUIRED PERSUANT TO LISTING RULE 704(7)(H)

Disclose the following matters concerning an appointment of director, chief executive officer, general manager or other executive officer of equivalent rank. If the answer to any questions is "yes", full details must be given.

(a)*Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner?
  • No  

       


    • TianjinZUS$ - ANNOUNCEMENT OF APPOINTMENT OF EXECUTIVE DIRECTOR

    Announcement Type: ANNOUNCEMENT OF APPOINTMENT
    Company: TIANJIN ZHONG XIN PHARM GROUP
    Stock Code/Name: T14 - TianjinZUS$

    ANNOUNCEMENT OF APPOINTMENT OF EXECUTIVE DIRECTOR *
    * Asterisks denote mandatory information
    Name of Announcer * TIANJIN ZHONG XIN PHARM GROUP  
    Company Registration No. 120000000004711  
    Announcement submitted on behalf of TIANJIN ZHONG XIN PHARM GROUP  
    Announcement is submitted with respect to * TIANJIN ZHONG XIN PHARM GROUP  
    Announcement is submitted by * Jiao Yan  
    Designation * Secretary to the Board  
    Date & Time of Broadcast 19-Dec-2012 17:41:34  
    Announcement No. 00063  
    >> ANNOUNCEMENT DETAILS
    The details of the announcement start here ...
    Date of Appointment * 18-12-2012  
    Name of Person* Zhou Hong  
    Age * 42  
    Country of principal residence * China  
    The Board's comments on this appointment (including rationale, selection criteria, and the search and nomination process) * approve of the decision of the Assembly of the Employees  
    Whether appointment is executive, and if so, the area of responsibility *
    Responsible for drug production  
    Job Title (e.g. Lead ID, AC Chairman, AC Member etc.) Employee Director  
    Working experience and occupation(s) during the past 10 years *
    For the period from July 1992 to December 2007, he held the position as Sales Executive, Deputy Director of Factory Workshop, Director of Factory Workshop, Leader of the technical process and Head of the Technology Department. From December 2007 to January 2010, he held the position of Deputy Director of Tianjin Zhong Xin Pharmaceutical Factory #6. From January 2010 to July 2011, he was promoted to the Executive Deputy Director of Tianjin Zhong Xin Pharmaceutical Factory #6. From July 2011 to date, he is the Director and Executive Deputy Secretary of Tianjin Zhong Xin Pharmaceutical Factory #6.  
    Interest * in the listed issuer and its subsidiaries *
    NIL  
    Familial relationship with any director and/or substantial shareholder of the listed issuer or of any of its principal subsidiaries *
    NIL  
    Conflict of interests (including any competing business) *
    NIL  
    >> OTHER DIRECTORSHIP#
    # These fields are not applicable for announcements of appointments pursuant to Listing Rule 704(9) or Catalist Rule 704(8).
    Past (for the last 5 years)
    NIL  
    Present
    NIL  
    >> INFORMATION REQUIRED PERSUANT TO LISTING RULE 704(7)(H)

    Disclose the following matters concerning an appointment of director, chief executive officer, general manager or other executive officer of equivalent rank. If the answer to any questions is "yes", full details must be given.

    (a)*Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner?
  • No  

       


    • Labels: , ,

    No comments:

    Post a Comment

    Subscribe to: Post Comments (Atom)